Dr. Filemon Dela Cruz, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Osteosarcoma
Studies Relapse
1 reported clinical trial
2 drugs studied
Affiliated Hospitals
More about Filemon Dela Cruz, MD
Clinical Trial Related9 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Filemon Dela Cruz, MD has experience with
- GM-CSF
- Humanized Monoclonal Antibody 3F8 (Hu3F8)
Breakdown of trials Filemon Dela Cruz, MD has run
Osteosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Filemon Dela Cruz, MD specialize in?
Filemon Dela Cruz, MD focuses on Osteosarcoma and Relapse. In particular, much of their work with Osteosarcoma has involved treating patients, or patients who are undergoing treatment.
Is Filemon Dela Cruz, MD currently recruiting for clinical trials?
No, Filemon Dela Cruz, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Filemon Dela Cruz, MD has studied deeply?
Yes, Filemon Dela Cruz, MD has studied treatments such as GM-CSF, Humanized Monoclonal Antibody 3F8 (Hu3F8).
What is the best way to schedule an appointment with Filemon Dela Cruz, MD?
Apply for one of the trials that Filemon Dela Cruz, MD is conducting.
What is the office address of Filemon Dela Cruz, MD?
The office of Filemon Dela Cruz, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.